Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U, Swamidas J, Khanna N, Engineer R, Merchant NH, Deshpande DD, Shrivastava S. Mahantshetty U, et al. Int J Gynecol Cancer. 2011 Aug;21(6):1110-6. doi: 10.1097/IGC.0b013e31821caa55. Int J Gynecol Cancer. 2011. PMID: 21633296
18-fluoro-deoxy-glucose positron emission tomography with computed tomography-based gross tumor volume estimation and validation with magnetic resonance imaging for locally advanced cervical cancers.
Upasani MN, Mahantshetty UM, Rangarajan V, Purandare N, Merchant N, Thakur M, Engineer R, Chopra S, Shrivastava SK. Upasani MN, et al. Int J Gynecol Cancer. 2012 Jul;22(6):1031-6. doi: 10.1097/IGC.0b013e318251046b. Int J Gynecol Cancer. 2012. PMID: 22622949
Comparison of 2 contouring methods of bone marrow on CT and correlation with hematological toxicities in non-bone marrow-sparing pelvic intensity-modulated radiotherapy with concurrent cisplatin for cervical cancer.
Mahantshetty U, Krishnatry R, Chaudhari S, Kanaujia A, Engineer R, Chopra S, Shrivastava S. Mahantshetty U, et al. Int J Gynecol Cancer. 2012 Oct;22(8):1427-34. doi: 10.1097/IGC.0b013e3182664b46. Int J Gynecol Cancer. 2012. PMID: 22932264 Clinical Trial.
Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K, Pötter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petrič P, Mahantshetty U, Jürgenliemk-Schulz IM, Rai B, Cooper R, Dörr W, Nout RA; EMBRACE Collaborative Group. Kirchheiner K, et al. Among authors: mahantshetty u. Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1088-98. doi: 10.1016/j.ijrobp.2015.12.363. Epub 2015 Dec 29. Int J Radiat Oncol Biol Phys. 2016. PMID: 26876955
Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale.
Gaffney D, Small B, Kitchener H, Young Ryu S, Viswanathan A, Trimble T, Covens A, Wilailak S, Lertkhachonsuk AA, Sitathanee C, Mahantshetty U, Fisher B, Springer S, Pollatz T, Spiller A, Bacon M, Jhingran A. Gaffney D, et al. Among authors: mahantshetty u. Int J Gynecol Cancer. 2016 Nov;26(9):1690-1693. doi: 10.1097/IGC.0000000000000823. Int J Gynecol Cancer. 2016. PMID: 27779548
American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries.
Suneja G, Brown D, Chang A, Erickson B, Fidarova E, Grover S, Mahantshetty U, Nag S, Narayan K, Bvochora-Nsingo M, Viegas C, Viswanathan AN, Lin MY, Gaffney D. Suneja G, et al. Among authors: mahantshetty u. Brachytherapy. 2017 Jan-Feb;16(1):85-94. doi: 10.1016/j.brachy.2016.10.007. Epub 2016 Dec 3. Brachytherapy. 2017. PMID: 27919654
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).
Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz CC, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ; INTERTECC Study Group. Mell LK, et al. Among authors: mahantshetty u. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):536-545. doi: 10.1016/j.ijrobp.2016.11.027. Epub 2016 Nov 23. Int J Radiat Oncol Biol Phys. 2017. PMID: 28126303 Clinical Trial.
230 results